approval

In: Artificial Intelligence

Innovations in artificial intelligence (AI) and machine learning (ML) are causing organizations to take a fresh look at the possibilities these technologies can offer. As you aim to bring your proofs of concept to production at an enterprise scale, you may experience challenges aligning with the strict security compliance requirementsContinue Reading

In: Finance

Vermilion Energy (NYSE:VET) on Monday announced that the Toronto Stock Exchange has approved the notice of the company’s intention to commence a normal course issuer bid (“NCIB”). The NCIB allows Vermilion to purchase up to 15.69M common shares, representing about 10% of its public float as at June 28, 2024,Continue Reading

In: Finance

Dmitry Vinogradov Barclays downgraded Pacira BioSciences (NASDAQ:PCRX) to equal weight from overweight following the U.S. FDA’s recent approval of a generic version of the company’s best-selling drug, Exparel (bupivacaine liposome). The firm cut its target price to $25 from $38 (~15% upside based on Wednesday’s close). Barclays noted that 78%Continue Reading